NO20003472L - TTS som inneholder en antioksidant - Google Patents

TTS som inneholder en antioksidant

Info

Publication number
NO20003472L
NO20003472L NO20003472A NO20003472A NO20003472L NO 20003472 L NO20003472 L NO 20003472L NO 20003472 A NO20003472 A NO 20003472A NO 20003472 A NO20003472 A NO 20003472A NO 20003472 L NO20003472 L NO 20003472L
Authority
NO
Norway
Prior art keywords
antioxidant
ethyl
tts containing
tts
carbamate
Prior art date
Application number
NO20003472A
Other languages
English (en)
Other versions
NO328390B1 (no
NO20003472D0 (no
Inventor
Bodo Asmussen
Michael Horstmann
Kai Koepke
Harry Tiemessen
Original Assignee
Novartis Ag
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10825116&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20003472(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag, Lohmann Therapie Syst Lts filed Critical Novartis Ag
Publication of NO20003472D0 publication Critical patent/NO20003472D0/no
Publication of NO20003472L publication Critical patent/NO20003472L/no
Publication of NO328390B1 publication Critical patent/NO328390B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Dental Preparations (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20003472A 1998-01-12 2000-07-05 Farmasoytisk sammensetning, anvendelse av antioksidant for a stabilisere nevnte sammensetning, samt transdermal innretning omfattende nevnte sammensetning NO328390B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9800526.7A GB9800526D0 (en) 1998-01-12 1998-01-12 Organic compounds
PCT/EP1999/000078 WO1999034782A1 (en) 1998-01-12 1999-01-08 Tts containing an antioxidant

Publications (3)

Publication Number Publication Date
NO20003472D0 NO20003472D0 (no) 2000-07-05
NO20003472L true NO20003472L (no) 2000-08-07
NO328390B1 NO328390B1 (no) 2010-02-08

Family

ID=10825116

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003472A NO328390B1 (no) 1998-01-12 2000-07-05 Farmasoytisk sammensetning, anvendelse av antioksidant for a stabilisere nevnte sammensetning, samt transdermal innretning omfattende nevnte sammensetning

Country Status (25)

Country Link
US (1) US6335031B1 (no)
EP (1) EP1047409B1 (no)
KR (1) KR100569051B1 (no)
CN (1) CN1129427C (no)
AT (1) ATE223711T1 (no)
AU (1) AU745661B2 (no)
BR (1) BR9906920A (no)
CA (1) CA2315784C (no)
CZ (1) CZ300598B6 (no)
DE (1) DE69902875T2 (no)
DK (1) DK1047409T3 (no)
ES (1) ES2184408T3 (no)
GB (1) GB9800526D0 (no)
HU (1) HU227159B1 (no)
ID (1) ID27503A (no)
IL (1) IL137100A (no)
MX (1) MXPA00006438A (no)
NO (1) NO328390B1 (no)
NZ (1) NZ505650A (no)
PL (1) PL201328B1 (no)
PT (1) PT1047409E (no)
RU (1) RU2219926C2 (no)
SK (1) SK284622B6 (no)
TR (2) TR200101021T2 (no)
WO (1) WO1999034782A1 (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1121104B1 (en) 1998-10-01 2005-01-12 Novartis AG New controlled release oral formulations for rivastigmine
FR2793689B1 (fr) * 1999-05-19 2001-08-24 Pf Medicament Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives
MXPA02005292A (es) * 1999-11-29 2002-12-11 Lohmann Therapie Syst Lts Sistemas terapeuticos transdermicos que tienen estabilidad mejorada y su produccion.
DE10107663B4 (de) * 2001-02-19 2004-09-09 Lts Lohmann Therapie-Systeme Ag Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
ITMI20020798A1 (it) * 2002-04-15 2003-10-15 F T Holding S A Cerotti transdermici a matrice adesiva siliconica stabilizzati con copolimeri metacrilici
FR2881653A1 (fr) * 2005-02-04 2006-08-11 Frederic Khodja Dispositif permettant l'administration en continu d'une dose physiologique controlee d'au moins un mineral ou une vitamine
TWI389709B (zh) * 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
WO2009022345A1 (en) * 2007-08-14 2009-02-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Phenyl carbamates for the treatment of multiple sclerosis
TW201431552A (zh) 2008-07-28 2014-08-16 Takeda Pharmaceutical 醫藥組成物
US20100087768A1 (en) * 2008-10-02 2010-04-08 Forlano Paula Transdermal drug delivery system for liquid active ingredient
BR112012017168B1 (pt) 2009-12-22 2022-03-15 Luye Pharma Ag Sistemas terapêuticos transdérmicos, seu processo de preparação, e usos de um polímero ou copolímero
US10076502B2 (en) 2009-12-22 2018-09-18 Luye Pharma Ag Transdermal therapeutic system for administering rivastigmine or derivatives thereof
ES2363395B1 (es) * 2010-01-20 2012-02-23 Farmalider, S.A. Composición farmacéutica l�?quida de rivastigmina o de una de sus sales de adición de �?cido para la administración por v�?a oral.
WO2011151359A1 (en) 2010-06-02 2011-12-08 Noscira, S.A. Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
DE102010026903A1 (de) 2010-07-12 2012-01-12 Amw Gmbh Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff
MX346041B (es) 2010-07-21 2017-03-03 3M Innovative Properties Company * Composiciones adhesivas transdermicas, dispositivos y metodos.
RS54173B1 (sr) 2010-12-14 2015-12-31 Acino Ag Transdermalni terapijski sistem za davanje aktivne supstance
KR101788802B1 (ko) * 2010-12-24 2017-10-20 주식회사 삼양바이오팜 리바스티그민을 함유하는 경피흡수제제
KR20120126898A (ko) * 2011-05-13 2012-11-21 에스케이케미칼주식회사 리바스티그민 또는 이의 염을 함유하는 경피 투여 조성물
WO2012161489A2 (ko) 2011-05-20 2012-11-29 에스케이케미칼 주식회사 리바스티그민 함유 패취
KR20120130073A (ko) * 2011-05-20 2012-11-28 에스케이케미칼주식회사 리바스티그민 함유 패취
EP2594261A1 (en) 2011-11-18 2013-05-22 Labtec GmbH Composition for transdermal administration of rivastigmine
DE102012000369A1 (de) 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
WO2013142339A1 (en) 2012-03-23 2013-09-26 Novartis Ag Transdermal therapeutic system and method
US10758494B2 (en) 2012-06-12 2020-09-01 KM Transderm Ltd. Rivastigmine-containing adhesive patch
EP2893927A4 (en) * 2012-09-03 2016-03-09 Nipro Patch Co Ltd SKIN PATCH
KR20140038237A (ko) 2012-09-20 2014-03-28 에스케이케미칼주식회사 리바스티그민의 안정성이 개선된 의약품
US9895320B2 (en) 2012-09-28 2018-02-20 KM Transderm Ltd. Transdermal patch with different viscosity hydrocarbon oils in the drug layer and the adhesive layer
WO2014111790A2 (en) 2013-01-15 2014-07-24 Zydus Technologies Limited Stable transdermal pharmaceutical drug delivery system comprising rivastigmine
EP3129012A4 (en) * 2014-04-08 2017-10-11 Teikoku Pharma USA, Inc. Rivastigmine transdermal compositions and methods of using the same
WO2015174502A1 (ja) 2014-05-15 2015-11-19 ニチバン株式会社 リバスチグミンを含有する貼付剤のための包装体
KR102823139B1 (ko) 2018-08-31 2025-06-19 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취
KR102710072B1 (ko) 2018-08-31 2024-09-24 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취
WO2021166987A1 (ja) * 2020-02-19 2021-08-26 大日本住友製薬株式会社 経皮吸収製剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL195004C (nl) * 1987-03-04 2003-11-04 Novartis Ag Fenylcarbamaat bevattend farmaceutisch preparaat.
GB9213322D0 (en) * 1992-06-23 1992-08-05 Efamol Holdings Antioxidant compositions
AU5716898A (en) * 1997-01-08 1998-08-03 Warner-Lambert Company Acetylcholinesterase inhibitors in combination with muscarinic agonists for the treatment of alzheimer's disease
DE69802498T2 (de) * 1997-01-17 2002-07-04 Takeda Chemical Industries, Ltd. Idebenon enthaltendes kombinationspräparat zur alzheimer behandlung

Also Published As

Publication number Publication date
CN1129427C (zh) 2003-12-03
SK10532000A3 (sk) 2000-11-07
HK1034036A1 (en) 2001-10-12
IL137100A0 (en) 2001-06-14
ES2184408T3 (es) 2003-04-01
PT1047409E (pt) 2002-12-31
CZ20002557A3 (cs) 2000-10-11
CA2315784A1 (en) 1999-07-15
ATE223711T1 (de) 2002-09-15
AU745661B2 (en) 2002-03-28
HUP0004300A2 (hu) 2001-05-28
CN1288375A (zh) 2001-03-21
CZ300598B6 (cs) 2009-06-24
EP1047409B1 (en) 2002-09-11
DE69902875T2 (de) 2003-05-22
HU227159B1 (en) 2010-09-28
DE69902875D1 (de) 2002-10-17
EP1047409A1 (en) 2000-11-02
AU2278599A (en) 1999-07-26
NZ505650A (en) 2002-10-25
HUP0004300A3 (en) 2003-05-28
TR200001688T2 (tr) 2000-11-21
PL341347A1 (en) 2001-04-09
NO328390B1 (no) 2010-02-08
IL137100A (en) 2004-12-15
PL201328B1 (pl) 2009-03-31
JP2002500178A (ja) 2002-01-08
MXPA00006438A (es) 2003-07-21
SK284622B6 (sk) 2005-08-04
US6335031B1 (en) 2002-01-01
KR100569051B1 (ko) 2006-04-10
JP3820103B2 (ja) 2006-09-13
NO20003472D0 (no) 2000-07-05
KR20010033072A (ko) 2001-04-25
RU2219926C2 (ru) 2003-12-27
ID27503A (id) 2001-04-12
GB9800526D0 (en) 1998-03-11
DK1047409T3 (da) 2002-12-30
CA2315784C (en) 2006-06-27
WO1999034782A1 (en) 1999-07-15
TR200101021T2 (tr) 2002-06-21
BR9906920A (pt) 2000-10-10

Similar Documents

Publication Publication Date Title
NO20003472D0 (no) TTS som inneholder en antioksidant
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
BR0107869A (pt) Composições farmacêuticas eletrogiradas
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
AR037081A1 (es) Composicion para el suministro transdermico de fentanilo
ATE383849T1 (de) Transdermale pharmazeutische zusammensetzung
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
BR0109150A (pt) Método para administração de um anestésico local a um indivìduo em necessidade de um efeito anestésico local, emplastro, composição, e, recipiente
ATE288256T1 (de) Dermale zusammensetzungen
TR199802108T2 (xx) �bandronat i�eren oral farmas�tik bir form�lasyon.
SE9301171D0 (sv) Pharmaceutical composition containing lipophilic drugs
ATE493973T1 (de) Irbesartan enthaltende pharmazeutische zusammensetzung
DE60019334D1 (de) Antivirale arznei
DE50005529D1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
HRP20010684B1 (hr) Izravno stlaciva matrica za kontrolirano otpustanje jednostruke dnevne doze klaritromicina
DK1303278T3 (da) Kombination af et transdermalt terapeutisk system og et oralt og/eller parenteralt præparat indeholdende dopaminagonister til behandling af dopaminerge sygdomme
MY141012A (en) Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
DK1300143T3 (da) Plaster som indeholder 4-biphenyleddikesyre
TR200200473T2 (tr) Rar selektif retinoid agonistleri.
TR200400241T4 (tr) Lasofoksifen'in transdermal olarak verilmesi
HRP20080178T3 (hr) Farmaceutski pripravak u obliku hidrogela za transdermalnu primjenu aktivnih tvari
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение
PT1144420E (pt) Fosfatidilinositois sulfatados a sua preparacao e a sua utilizacao
DK0768896T3 (da) Lavdoserede steroidtabletter, der indeholder gallussyreestere som antioxidant, fremgangsmåde til fremstilling og anvendelse

Legal Events

Date Code Title Description
MK1K Patent expired